Objective: To determine the Irish prevalence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), the AIRE mutations involved and clinical features of this population.
Methods: All patients were identified through paediatricians and endocrinologists in Ireland. Patients were invited to attend a multidisciplinary clinic.
Results: Thirty-one patients (2-56 years), 18 female, were identified from 19 families giving an Irish prevalence of 1:130,000. Twenty-six patients had hypoparathyroidism, 21 had adrenal insufficiency (AI) and 10 of 16 had ovarian failure. Three affected patients have died. Many with hypoparathyroidism were resistant to 1-alpha-vitamin D. Two needed daily PTH injections. Mineralocorticoid deficiency as the first manifestation of AI was common. Chronic intra-oral candidiasis affected 25 patients and three had leukoplakia. Two had keratoconjuntivitis. Of 22 with AIRE gene analysis, three different mutations were identified, one of which is novel.
Conclusion: APECED is rare in Ireland. We saw a significant amount of non-endocrine disease but no ectodermal dystrophy. AIRE gene analysis reassured many siblings and identified individuals with APECED prior to any symptoms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/jpem.2006.19.11.1343 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bronchiectasis in a patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: a case report.
BMC Pulm Med
October 2024
Respiratory Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
Article Synopsis
- APECED is a rare genetic syndrome characterized by autoimmune issues that can affect multiple systems, including the lungs, and is particularly prevalent in the Sardinian population.
- A 49-year-old Sardinian woman with APECED presented to a bronchiectasis clinic with chronic respiratory issues, and her CT scan revealed significant bronchiectasis along with infections from P. aeruginosa, MRSA, and M. intracellulare.
- This case marks the first known lung involvement in a Sardinian APECED patient, highlighting the need for increased awareness and earlier screening for pulmonary complications in similar patients.
Uncovering ASO-Targetable Deep Intronic Variants: Insights and Therapeutic Implications.
DNA Cell Biol
October 2024
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.
High-throughput DNA sequencing has accelerated the discovery of disease-causing genetic variants, yet only in 10-40% of cases yield a genetic diagnosis. Increased implementation of genome sequencing has enabled a deeper exploration of the noncoding genome and recognition of noncoding variants as major contributors to disease. In a recent study, we identified a deep intronic variant in the AutoImmune REgulator () gene (c.
View Article and Find Full Text PDFWhere AIRE we now? Where AIRE we going?
Curr Opin Allergy Clin Immunol
December 2024
Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Treviso.
Purpose Of Review: The purpose of the review is to describe the most recent advancement in understanding of the pivotal role of autoimmune regulator ( AIRE ) gene expression in central and peripheral tolerance, and the implications of its impairment in the genetic and pathogenesis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) manifestations with insight into possible treatment options.
Recent Findings: AIRE gene expression has an important role of central and peripheral tolerance. Different AIRE gene mutations cause APECED, whereas polymorphisms and some variants may be implicated in development of other more frequently autoimmune diseases.
A deep intronic splice-altering variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion.
Sci Transl Med
September 2024
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.
Article Synopsis
- APECED is a serious genetic autoimmune disorder linked to variants in the autoimmune regulator (AIRE) gene, with 16% of evaluated patients lacking known harmful variants, most of whom are of Puerto Rican descent.
- Researchers discovered a deep intronic variant (c.1504-818 G>A) in these patients that causes a cryptic splice site leading to a dysfunctional protein through pseudoexon inclusion.
- They developed an antisense oligonucleotide (ASO) that corrected this genetic issue, demonstrating the potential for targeted treatments in APECED patients.
Decreased T-cell response against latent cytomegalovirus infection does not correlate with anti-IFN autoantibodies in patients with APECED.
APMIS
November 2024
Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Article Synopsis
- APECED is a genetic immune disorder that affects various hormone-producing glands and increases vulnerability to candidiasis, with recent findings linking it to more severe COVID-19 and varicella infections.
- In a study comparing APECED patients and healthy individuals, a higher percentage of APECED patients had anti-CMV IgG antibodies, although their antibody levels weren't significantly different from controls.
- However, APECED patients showed lower levels of CMV-specific T cells, indicating a weakened immune response to CMV and solidifying the idea that APECED is associated with greater vulnerability to viral infections.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!